Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

9 Items

per page
  1. Oligomycin A
    A5588 Oligomycin A
     1 Citation
    Target: Synthases/Synthetases
    Summary: Mitochondrial ATP synthase Inhibitor
  2. LY335979 (Zosuquidar 3HCL)
    A8549 LY335979 (Zosuquidar 3HCL)
     1 Citation
    Target: P-glycoprotein (P-gp)
    Summary: Pgp (P-glycoprotein) inhibitor
      insoluble in EtOH; ≥17.1 mg/mL
  3. Verapamil HCl
    B1867 Verapamil HCl
     1 Citation
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: L-type calcium channel blocker
      ≥14.45 mg/mL
  4. Tolbutamide
    B2194 Tolbutamide
    Target: cAMP|Sulfonylurea receptors
    Summary: first generation potassium channel blocker
      insoluble in H2O; ≥10.05 mg/mL
  5. Tariquidar
    A8208 Tariquidar
     2 Citation
    Target: P-glycoprotein (P-gp)
    Summary: P-glycoprotein inhibitor,potent and non-competitive
      insoluble in H2O; insoluble in EtOH; ≥16.17 mg/mL
  6. AR-C155858
    A3185 AR-C155858
    Target: Monocarboxylate transporters (MCTs)
    Summary: MCT1 and MCT2 inhibitor
      insoluble in H2O; ≥52.5 mg/mL
  7. NNC 55-0396
    A3662 NNC 55-0396
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: T-type calcium channel blocker
      Soluble to 25 mM in sterile water
  8. Tariquidar methanesulfonate, hydrate
    A3859 Tariquidar methanesulfonate, hydrate
    Target: P-glycoprotein (P-gp)
    Summary: P-glycoprotein inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥56.2 mg/mL
  9. Zosuquidar
    A3956 Zosuquidar
    Target: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)
    Summary: MDR modulator
      Soluble in DMSO

9 Items

per page